OBG3 FRAGMENTS INHIBITING THE CONVERSION OF ACTIVE OBG3 INTO LESS ACTIVE OBG3 AND OTHER COMPOSITIONS FOR TREATMENT OF METABOLIC DISORDERS

Details for Australian Patent Application No. 2003223070 (hide)

Owner GENSET SA

Inventors LUCAS, John; DIALYNAS, Deno

Pub. Number AU-A-2003223070

PCT Number PCT/IB03/01888

PCT Pub. Number WO2003/097689

Priority 60/381,603 17.05.02 US

Filing date 7 May 2003

Wipo publication date 2 December 2003

International Classifications

C07K 014/575 Peptides having more than 20 amino acids

C12N 015/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

A61K 038/22 Medicinal preparations containing peptides - Hormones

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/381,603 17.05.02 US

29 January 2004 Application Open to Public Inspection

  Published as AU-A-2003223070

3 February 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003223071-Pharmaceutical combination of PDE5 inhibitors with ACE inhibitors

2003223069-Flavoured oil-in-water emulsions for food applications